Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027960 (
mole
)
21,279
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dynamitin is a commonly used inhibitor of cytoplasmic dynein-based motility in living cells. Dynamitin does not inhibit dynein directly but instead acts by causing disassembly of dynactin, a multiprotein complex required for dynein-based movement. In dynactin,
dynamitin
is closely associated with the subunits p150(Glued) and p24, which together form the shoulder and projecting arm structures of the dynactin molecule. In this study, we explore the way in which exogenous
dynamitin
effects dynactin disruption. We find that pure, recombinant
dynamitin
is an elongated protein with a strong propensity for self-assembly. Titration experiments reveal that free
dynamitin
binds dynactin before it causes release of subunits. When
dynamitin
is added to dynactin at an equimolar ratio of exogenous
dynamitin
subunits to endogenous
dynamitin
subunits (1x= 4 mol of exogenous
dynamitin
per
mole
of dynactin), exogenous
dynamitin
exchanges with endogenous
dynamitin
, and partial release of p150(Glued) is observed. When added in vast excess (> or =25x; 100 mol of exogenous
dynamitin
per
mole
of dynactin), recombinant
dynamitin
causes complete release of both p150(Glued) subunits, two dynamitins and one p24, but not other dynactin subunits. Our data suggest that
dynamitin
mediates disruption of dynactin by binding to endogenous
dynamitin
subunits. This binding destabilizes the shoulder structure that links the p150(Glued) arm to the Arp1 filament and leads to subunit release.
...
PMID:Mechanism of dynamitin-mediated disruption of dynactin. 1744 14